Novonesis completes acquisition of dsm-firmenich's Feed Enzyme Alliance share
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
The transaction follows the satisfaction of all closing conditions.
Stock price
NOVONESIS
Loading chart...
This acquisition was initially disclosed on February 11, 2025, according to the company.
More from this issuer
Related coverage
6 Nov 2025, 07:01NSISb.CO
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
20 Aug 2025, 15:47NSISb.CO
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.